Jarvik G P, Brunzell J D, Austin M A, Krauss R M, Motulsky A G, Wijsman E
Department of Medicine, University of Washington, Seattle.
Arterioscler Thromb. 1994 Nov;14(11):1687-94. doi: 10.1161/01.atv.14.11.1687.
The genetic basis of familial combined hyperlipidemia (FCHL) has eluded investigators for 20 years, despite the apparent segregation of FCHL as an autosomal dominant disorder affecting 1% to 2% of individuals. Etiologic heterogeneity and additive effects of traits controlled by other genetic loci have been suggested. Two traits have been implicated in FCHL. The first is the predominance of a small, dense low-density lipoprotein (LDL), LDL subclass phenotype B, which segregates as a mendelian trait. The second is a mendelian locus with large effects on apolipoprotein (apo) B levels that is defined by complex segregation analysis (predicted apoB level genotype). This study shows that these factors appear to be separate genetic effects, both of which aid in the prediction of FCHL in four large pedigrees. The results suggest that FCHL may be best predicted by a threshold model in which apoB level genotype and LDL subclass phenotype each act to increase the risk of FCHL. Heterogeneity in the transmission of apoB levels among families is suggested, supporting the etiologic heterogeneity of FCHL. These results emphasize the advantages inherent in the study of large pedigrees when disease heterogeneity is suspected.
家族性混合性高脂血症(FCHL)的遗传基础困扰了研究人员20年,尽管FCHL显然以常染色体显性疾病的形式遗传,影响着1%至2%的人群。病因的异质性以及其他基因位点所控制性状的累加效应已被提及。有两个性状与FCHL有关。第一个是小而密的低密度脂蛋白(LDL)占优势,即LDL亚类B型,它作为孟德尔性状进行遗传分离。第二个是对载脂蛋白(apo)B水平有重大影响的孟德尔基因座,这是通过复杂分离分析确定的(预测的apoB水平基因型)。本研究表明,这些因素似乎是独立的遗传效应,二者都有助于在四个大型家系中预测FCHL。结果表明,FCHL可能最好通过一个阈值模型来预测,在该模型中,apoB水平基因型和LDL亚类表型各自增加FCHL的风险。提示了apoB水平在家族间传递存在异质性,支持了FCHL病因的异质性。这些结果强调了在怀疑疾病异质性时研究大型家系所固有的优势。